MOESM1 of Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

  • Hui Xia (Creator)
  • Susan Van Den Hof (KNCV Tuberculosis Foundation, The Hague, National Institute of Public Health and the Environment) (Contributor)
  • Franciscus Cobelens (Creator)
  • Yang Zhou (Creator)
  • Bing Zhao (Creator)
  • Shengfen Wang (Creator)
  • Yanlin Zhao (Creator)
  • Zhao Yanlin (Contributor)

Dataset

Description

Additional file 1: Table S1. Database for Univariable and multivariable analysis of risk factors for phenotypic and genotypic pyrazinamide resistance.
Date made available2020
PublisherFigshare

Cite this